Dibenz [b,e] oxepin derivatives
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsHiroshi Takizawa, Osamu Morita, Yoshimasa Oiji, Tamotsu Hashimoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsHiroshi Takizawa, Osamu Morita, Yoshimasa Oiji, Tamotsu Hashimoto
Estimating the term…
Novel dibenz [b,e] oxepin derivatives represented by the general formula: ##STR1## wherein R.sub.11 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R.sub.21 represents ##STR2## wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n represents 0 or an integer of 1 to 3 ##STR3## or (3) --NH--(CH.sub.2).sub.n --Y, wherein Y represents an alkylamino group containing 1 to 5 carbon atoms, an aralkyl group containing 7 to 20 carbon atoms, a substituted aralkyl group, an aralkyloxy group containing 7 to 20 carbon atoms, an aralkylamino group containing 7 to 20 carbon atoms, a heterocyclic ring or a substituted heterocyclic ring, and n has the same meaning as defined before; provided that when R.sub.11 represents an alkyl group, an alkoxy group or a halogen atom, X does not represent a hydrogen atom; and the pharmaceutically acceptable acid addition salts thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutical carrier and, as an active ingredient, an effective amount of a dibenz [b,e] oxepin derivative represented by the following general formula: ##STR4## wherein R.sub.1 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R.sub.2 represents ##STR5## wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n has the same meaning as defined before ##STR6## or (3) --NH--(CH.sub.2).sub.n --Y, wherein Y and n have the same meaning as defined above; and the pharmaceutically acceptable acid addition salts thereof. Compound I, represented by the general formula (I), has antichlolinergic, antihistaminergic, antiasthmatic and antiplatelet aggregation activities, and is therefore useful as a sposmolysant, an antihistaminic, an antiasthmatic agent and as a medicament for cardiovascular or cerebrovascular diseases, respectively.
A dibenz[b,e]oxepin compound represented by the formula:
2-ethyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
2-methyl-11-{3-diethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin.
2-ethyl-11-{3-(dimethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin
2-ethyl-11-{2-(dimethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
2-cyclohexyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxe pin.
Dependencies are inferred from the claim text.